|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the catalytic subunit of camp-dependent protein kinase complexed with a phosphorylated substrate peptide and detergent
|
|
Structure:
|
 |
Amp-dependent protein kinase, alpha-catalytic subunit. Chain: e. Synonym: pka c-alpha. Engineered: yes. Camp-dependent protein kinase inhibitor, muscle/brain form. Chain: s. Fragment: residues 5-24. Synonym: pki-alpha. Engineered: yes.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: the peptide was chemically synthesized. The sequence of the peptide is naturally found in mus musculus (mouse).
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
Madhusudan,E.A.Trafny,N.-H.Xuong,J.A.Adams,L.F.Ten Eyck,S.S.Taylor, J.M.Sowadski
|
Key ref:
|
 |
Madhusudan
et al.
(1994).
cAMP-dependent protein kinase: crystallographic insights into substrate recognition and phosphotransfer.
Protein Sci,
3,
176-187.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Jul-01
|
Release date:
|
01-Aug-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain E:
E.C.2.7.11.11
- cAMP-dependent protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Protein Sci
3:176-187
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
cAMP-dependent protein kinase: crystallographic insights into substrate recognition and phosphotransfer.
|
|
Madhusudan,
E.A.Trafny,
N.H.Xuong,
J.A.Adams,
L.F.Ten Eyck,
S.S.Taylor,
J.M.Sowadski.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of ternary and binary substrate complexes of the catalytic
subunit of cAMP-dependent protein kinase has been refined at 2.2 and 2.25 A
resolution, respectively. The ternary complex contains ADP and a 20-residue
substrate peptide, whereas the binary complex contains the phosphorylated
substrate peptide. These 2 structures were refined to crystallographic R-factors
of 17.5 and 18.1%, respectively. In the ternary complex, the hydroxyl oxygen OG
of the serine at the P-site is 2.7 A from the OD1 atom of Asp 166. This is the
first crystallographic evidence showing the direct interaction of this invariant
carboxylate with a peptide substrate, and supports the predicted role of Asp 166
as a catalytic base and as an agent to position the serine -OH for nucleophilic
attack. A comparison of the substrate and inhibitor ternary complexes places the
hydroxyl oxygen of the serine 2.7 A from the gamma-phosphate of ATP and supports
a direct in-line mechanism for phosphotransfer. In the binary complex, the
phosphate on the Ser interacts directly with the epsilon N of Lys 168, another
conserved residue. In the ternary complex containing ATP and the inhibitor
peptide, Lys 168 interacts electrostatically with the gamma-phosphate of ATP
(Zheng J, Knighton DR, Ten Eyck LF, Karlsson R, Xuong NH, Taylor SS, Sowadski
JM, 1993, Biochemistry 32:2154-2161). Thus, Lys 168 remains closely associated
with the phosphate in both complexes. A comparison of this binary complex
structure with the recently solved structure of the ternary complex containing
ATP and inhibitor peptide also reveals that the phosphate atom traverses a
distance of about 1.5 A following nucleophilic attack by serine and transfer to
the peptide. No major conformational changes of active site residues are seen
when the substrate and product complexes are compared, although the binary
complex with the phosphopeptide reveals localized changes in conformation in the
region corresponding to the glycine-rich loop. The high B-factors for this loop
support the conclusion that this structural motif is a highly mobile segment of
the protein.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Fig. 5. Diagramofesentialresiduesthatcontribtetonucleotidebindingndcatalysis. A: Inhibitorternarycomplex. Dis-
tancesaretakenfromtheternarycomplexof C:IPZO:ATP (Zhengetal.,1993~).Thecrystalsweresoaked in MnZ*, andboth
theinhibitorandtheactivatingmetalsareshown (++) (Zhengetal., 1993~).The activating metal bridges the p- andy-phosphates,
whereastheinhibitorymetalbridgesthe Y- andy-phospates.Thearrowbridgesthemethylsidechain f theP-siteAlaand
they-phosphate of ATP. B: Substrateternarycomplex. C: Phosphorylatedsubstratebinarycomplex.
|
 |
Figure 8.
ig. 8. Stereoviewshowingthesuperimposition
f inaryandternarycomplexesandhigh-
lighting localized chagesin the glycine-rich
loop. Overallcomparison of the a-carbon back-
bone of the pper omain(residues 15-127) of
the ternary complexwith MnATP (red),thebi-
nary withproductpeptide (blue), and
the mammalianC-subunitbinarycomplexwih
di-iodinated Tyr 7 PKI(5-24) (green). In hese 3
structures,thelargelobesaresuperimposedand
are omitted from thedrawing, as theysho no
major conformational changes.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the Protein Society:
Protein Sci
(1994,
3,
176-187)
copyright 1994.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Hughes,
F.Elustondo,
A.Di Fonzo,
F.G.Leroux,
A.C.Wong,
A.P.Snijders,
S.J.Matthews,
and
P.Cherepanov
(2012).
Crystal structure of human CDC7 kinase in complex with its activator DBF4.
|
| |
Nat Struct Mol Biol,
19,
1101-1107.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.S.Hong,
A.Allali-Hassani,
W.Tempel,
P.J.Finerty,
F.Mackenzie,
S.Dimov,
M.Vedadi,
and
H.W.Park
(2010).
Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.
|
| |
J Biol Chem,
285,
16330-16340.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Pérez,
and
E.Cardemil
(2010).
Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: the relevance of Glu299 and Leu460 for nucleotide binding.
|
| |
Protein J,
29,
299-305.
|
 |
|
|
|
|
 |
F.Shi,
S.E.Telesco,
Y.Liu,
R.Radhakrishnan,
and
M.A.Lemmon
(2010).
ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.
|
| |
Proc Natl Acad Sci U S A,
107,
7692-7697.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Bereta,
B.Wang,
P.D.Kiser,
W.Baehr,
G.F.Jang,
and
K.Palczewski
(2010).
A functional kinase homology domain is essential for the activity of photoreceptor guanylate cyclase 1.
|
| |
J Biol Chem,
285,
1899-1908.
|
 |
|
|
|
|
 |
J.Jung,
Y.Sugita,
and
S.Ten-No
(2010).
Moller-Plesset perturbation theory gradient in the generalized hybrid orbital quantum mechanical and molecular mechanical method.
|
| |
J Chem Phys,
132,
084106.
|
 |
|
|
|
|
 |
N.Kumar,
and
D.Mohanty
(2010).
Identification of substrates for Ser/Thr kinases using residue-based statistical pair potentials.
|
| |
Bioinformatics,
26,
189-197.
|
 |
|
|
|
|
 |
R.Krishnamurty,
and
D.J.Maly
(2010).
Biochemical mechanisms of resistance to small-molecule protein kinase inhibitors.
|
| |
ACS Chem Biol,
5,
121-138.
|
 |
|
|
|
|
 |
E.D.Lew,
C.M.Furdui,
K.S.Anderson,
and
J.Schlessinger
(2009).
The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations.
|
| |
Sci Signal,
2,
ra6.
|
 |
|
|
|
|
 |
F.Xu,
P.Du,
H.Shen,
H.Hu,
Q.Wu,
J.Xie,
and
L.Yu
(2009).
Correlated mutation analysis on the catalytic domains of serine/threonine protein kinases.
|
| |
PLoS One,
4,
e5913.
|
 |
|
|
|
|
 |
I.V.Khavrutskii,
B.Grant,
S.S.Taylor,
and
J.A.McCammon
(2009).
A transition path ensemble study reveals a linchpin role for Mg(2+) during rate-limiting ADP release from protein kinase A.
|
| |
Biochemistry,
48,
11532-11545.
|
 |
|
|
|
|
 |
J.Yang,
E.J.Kennedy,
J.Wu,
M.S.Deal,
J.Pennypacker,
G.Ghosh,
and
S.S.Taylor
(2009).
Contribution of Non-catalytic Core Residues to Activity and Regulation in Protein Kinase A.
|
| |
J Biol Chem,
284,
6241-6248.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Fukuda,
S.Gupta,
K.Chen,
C.Wu,
and
J.Qin
(2009).
The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.
|
| |
Mol Cell,
36,
819-830.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.P.Kuntamalla,
E.Kunttas-Tatli,
U.Karandikar,
C.P.Bishop,
and
A.P.Bidwai
(2009).
Drosophila protein kinase CK2 is rendered temperature-sensitive by mutations of highly conserved residues flanking the activation segment.
|
| |
Mol Cell Biochem,
323,
49-60.
|
 |
|
|
|
|
 |
A.Sabò,
M.Lusic,
A.Cereseto,
and
M.Giacca
(2008).
Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.
|
| |
Mol Cell Biol,
28,
2201-2212.
|
 |
|
|
|
|
 |
J.C.Hagopian,
C.T.Ma,
B.R.Meade,
C.P.Albuquerque,
J.C.Ngo,
G.Ghosh,
P.A.Jennings,
X.D.Fu,
and
J.A.Adams
(2008).
Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1.
|
| |
J Mol Biol,
382,
894-909.
|
 |
|
|
|
|
 |
T.Timm,
A.Marx,
S.Panneerselvam,
E.Mandelkow,
and
E.M.Mandelkow
(2008).
Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein.
|
| |
BMC Neurosci,
9,
S9.
|
 |
|
|
|
|
 |
D.L.Johnson,
and
J.B.Mahony
(2007).
Chlamydophila pneumoniae PknD exhibits dual amino acid specificity and phosphorylates Cpn0712, a putative type III secretion YscD homolog.
|
| |
J Bacteriol,
189,
7549-7555.
|
 |
|
|
|
|
 |
E.D.Lew,
J.H.Bae,
E.Rohmann,
B.Wollnik,
and
J.Schlessinger
(2007).
Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation.
|
| |
Proc Natl Acad Sci U S A,
104,
19802-19807.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Neuberger,
G.Schneider,
and
F.Eisenhaber
(2007).
pkaPS: prediction of protein kinase A phosphorylation sites with the simplified kinase-substrate binding model.
|
| |
Biol Direct,
2,
1.
|
 |
|
|
|
|
 |
M.Montenegro,
M.Garcia-Viloca,
A.González-Lafont,
and
J.M.Lluch
(2007).
Comparative study of the prereactive Protein Kinase A Michaelis complex with Kemptide substrate.
|
| |
J Comput Aided Mol Des,
21,
603-615.
|
 |
|
|
|
|
 |
K.L.Damm,
and
H.A.Carlson
(2006).
Gaussian-weighted RMSD superposition of proteins: a structural comparison for flexible proteins and predicted protein structures.
|
| |
Biophys J,
90,
4558-4573.
|
 |
|
|
|
|
 |
L.Milanese,
A.Espinosa,
J.M.Campos,
M.A.Gallo,
and
A.Entrena
(2006).
Insight into the inhibition of human choline kinase: homology modeling and molecular dynamics simulations.
|
| |
ChemMedChem,
1,
1216-1228.
|
 |
|
|
|
|
 |
Y.Cheng,
Y.Zhang,
and
J.A.McCammon
(2006).
How does activation loop phosphorylation modulate catalytic activity in the cAMP-dependent protein kinase: a theoretical study.
|
| |
Protein Sci,
15,
672-683.
|
 |
|
|
|
|
 |
Z.A.Knight,
B.Gonzalez,
M.E.Feldman,
E.R.Zunder,
D.D.Goldenberg,
O.Williams,
R.Loewith,
D.Stokoe,
A.Balla,
B.Toth,
T.Balla,
W.A.Weiss,
R.L.Williams,
and
K.M.Shokat
(2006).
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.
|
| |
Cell,
125,
733-747.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Lu,
C.F.Wong,
and
J.A.McCammon
(2005).
Release of ADP from the catalytic subunit of protein kinase A: a molecular dynamics simulation study.
|
| |
Protein Sci,
14,
159-168.
|
 |
|
|
|
|
 |
C.Drahl,
B.F.Cravatt,
and
E.J.Sorensen
(2005).
Protein-reactive natural products.
|
| |
Angew Chem Int Ed Engl,
44,
5788-5809.
|
 |
|
|
|
|
 |
J.López-Prados,
F.Cuevas,
N.C.Reichardt,
J.L.de Paz,
E.Q.Morales,
and
M.Martín-Lomas
(2005).
Design and synthesis of inositolphosphoglycan putative insulin mediators.
|
| |
Org Biomol Chem,
3,
764-786.
|
 |
|
|
|
|
 |
J.Wu,
J.Yang,
N.Kannan,
Madhusudan,
N.H.Xuong,
L.F.Ten Eyck,
and
S.S.Taylor
(2005).
Crystal structure of the E230Q mutant of cAMP-dependent protein kinase reveals an unexpected apoenzyme conformation and an extended N-terminal A helix.
|
| |
Protein Sci,
14,
2871-2879.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Kannan,
and
A.F.Neuwald
(2004).
Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
|
| |
Protein Sci,
13,
2059-2077.
|
 |
|
|
|
|
 |
B.E.Aubol,
B.Nolen,
J.Shaffer,
G.Ghosh,
and
J.A.Adams
(2003).
Novel destabilization of nucleotide binding by the gamma phosphate of ATP in the yeast SR protein kinase Sky1p.
|
| |
Biochemistry,
42,
12813-12820.
|
 |
|
|
|
|
 |
B.Huang,
G.Zeng,
A.Y.Ng,
and
M.Cai
(2003).
Identification of novel recognition motifs and regulatory targets for the yeast actin-regulating kinase Prk1p.
|
| |
Mol Biol Cell,
14,
4871-4884.
|
 |
|
|
|
|
 |
R.I.Brinkworth,
R.A.Breinl,
and
B.Kobe
(2003).
Structural basis and prediction of substrate specificity in protein serine/threonine kinases.
|
| |
Proc Natl Acad Sci U S A,
100,
74-79.
|
 |
|
|
|
|
 |
E.Y.Chan,
S.L.Stang,
D.A.Bottorff,
and
J.C.Stone
(2002).
Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity.
|
| |
Mol Carcinog,
33,
189-197.
|
 |
|
|
|
|
 |
J.M.Neu,
S.V.MacMillan,
J.R.Nodwell,
and
G.D.Wright
(2002).
StoPK-1, a serine/threonine protein kinase from the glycopeptide antibiotic producer Streptomyces toyocaensis NRRL 15009, affects oxidative stress response.
|
| |
Mol Microbiol,
44,
417-430.
|
 |
|
|
|
|
 |
Madhusudan,
P.Akamine,
N.H.Xuong,
and
S.S.Taylor
(2002).
Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase.
|
| |
Nat Struct Biol,
9,
273-277.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.I.Brinkworth,
J.Horne,
and
B.Kobe
(2002).
A computational analysis of substrate binding strength by phosphorylase kinase and protein kinase A.
|
| |
J Mol Recognit,
15,
104-111.
|
 |
|
|
|
|
 |
S.Fieulaine,
S.Morera,
S.Poncet,
I.Mijakovic,
A.Galinier,
J.Janin,
J.Deutscher,
and
S.Nessler
(2002).
X-ray structure of a bifunctional protein kinase in complex with its protein substrate HPr.
|
| |
Proc Natl Acad Sci U S A,
99,
13437-13441.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Wang,
X.Y.Huang,
and
P.A.Cole
(2001).
Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
|
| |
Biochemistry,
40,
2004-2010.
|
 |
|
|
|
|
 |
M.C.Hutter,
and
V.Helms
(2000).
Phosphoryl transfer by a concerted reaction mechanism in UMP/CMP-kinase.
|
| |
Protein Sci,
9,
2225-2231.
|
 |
|
|
|
|
 |
Q.Ni,
J.Shaffer,
and
J.A.Adams
(2000).
Insights into nucleotide binding in protein kinase A using fluorescent adenosine derivatives.
|
| |
Protein Sci,
9,
1818-1827.
|
 |
|
|
|
|
 |
R.T.Aimes,
W.Hemmer,
and
S.S.Taylor
(2000).
Serine-53 at the tip of the glycine-rich loop of cAMP-dependent protein kinase: role in catalysis, P-site specificity, and interaction with inhibitors.
|
| |
Biochemistry,
39,
8325-8332.
|
 |
|
|
|
|
 |
T.J.Hirai,
I.Tsigelny,
and
J.A.Adams
(2000).
Catalytic assessment of the glycine-rich loop of the v-Fps oncoprotein using site-directed mutagenesis.
|
| |
Biochemistry,
39,
13276-13284.
|
 |
|
|
|
|
 |
D.M.Daigle,
G.A.McKay,
P.R.Thompson,
and
G.D.Wright
(1999).
Aminoglycoside antibiotic phosphotransferases are also serine protein kinases.
|
| |
Chem Biol,
6,
11-18.
|
 |
|
|
|
|
 |
I.Tsigelny,
J.P.Greenberg,
S.Cox,
W.L.Nichols,
S.S.Taylor,
and
L.F.Ten Eyck
(1999).
600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase.
|
| |
Biopolymers,
50,
513-524.
|
 |
|
|
|
|
 |
J.Shaffer,
and
J.A.Adams
(1999).
An ATP-linked structural change in protein kinase A precedes phosphoryl transfer under physiological magnesium concentrations.
|
| |
Biochemistry,
38,
5572-5581.
|
 |
|
|
|
|
 |
M.C.Hutter,
and
V.Helms
(1999).
Influence of key residues on the reaction mechanism of the cAMP-dependent protein kinase.
|
| |
Protein Sci,
8,
2728-2733.
|
 |
|
|
|
|
 |
N.Narayana,
T.C.Diller,
K.Koide,
M.E.Bunnage,
K.C.Nicolaou,
L.L.Brunton,
N.H.Xuong,
L.F.Ten Eyck,
and
S.S.Taylor
(1999).
Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
|
| |
Biochemistry,
38,
2367-2376.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.T.Skamnaki,
D.J.Owen,
M.E.Noble,
E.D.Lowe,
G.Lowe,
N.G.Oikonomakos,
and
L.N.Johnson
(1999).
Catalytic mechanism of phosphorylase kinase probed by mutational studies.
|
| |
Biochemistry,
38,
14718-14730.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Sondhi,
W.Xu,
Z.Songyang,
M.J.Eck,
and
P.A.Cole
(1998).
Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
|
| |
Biochemistry,
37,
165-172.
|
 |
|
|
|
|
 |
F.A.al-Obeidi,
J.J.Wu,
and
K.S.Lam
(1998).
Protein tyrosine kinases: structure, substrate specificity, and drug discovery.
|
| |
Biopolymers,
47,
197-223.
|
 |
|
|
|
|
 |
J.Lisnock,
A.Tebben,
B.Frantz,
E.A.O'Neill,
G.Croft,
S.J.O'Keefe,
B.Li,
C.Hacker,
S.de Laszlo,
A.Smith,
B.Libby,
N.Liverton,
J.Hermes,
and
P.LoGrasso
(1998).
Molecular basis for p38 protein kinase inhibitor specificity.
|
| |
Biochemistry,
37,
16573-16581.
|
 |
|
|
|
|
 |
J.Szczepanowska,
U.Ramachandran,
C.J.Herring,
J.M.Gruschus,
J.Qin,
E.D.Korn,
and
H.Brzeska
(1998).
Effect of mutating the regulatory phosphoserine and conserved threonine on the activity of the expressed catalytic domain of Acanthamoeba myosin I heavy chain kinase.
|
| |
Proc Natl Acad Sci U S A,
95,
4146-4151.
|
 |
|
|
|
|
 |
N.Narayana,
P.Akamine,
N.H.Xuong,
and
S.S.Taylor
(1998).
Crystallization and preliminary X-ray analysis of the unliganded recombinant catalytic subunit of cAMP-dependent protein kinase.
|
| |
Acta Crystallogr D Biol Crystallogr,
54,
1401-1404.
|
 |
|
|
|
|
 |
P.R.Romano,
M.T.Garcia-Barrio,
X.Zhang,
Q.Wang,
D.R.Taylor,
F.Zhang,
C.Herring,
M.B.Mathews,
J.Qin,
and
A.G.Hinnebusch
(1998).
Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2.
|
| |
Mol Cell Biol,
18,
2282-2297.
|
 |
|
|
|
|
 |
P.Saylor,
C.Wang,
T.J.Hirai,
and
J.A.Adams
(1998).
A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps.
|
| |
Biochemistry,
37,
12624-12630.
|
 |
|
|
|
|
 |
S.Shaltiel,
S.Cox,
and
S.S.Taylor
(1998).
Conserved water molecules contribute to the extensive network of interactions at the active site of protein kinase A.
|
| |
Proc Natl Acad Sci U S A,
95,
484-491.
|
 |
|
|
|
|
 |
E.D.Lowe,
M.E.Noble,
V.T.Skamnaki,
N.G.Oikonomakos,
D.J.Owen,
and
L.N.Johnson
(1997).
The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition.
|
| |
EMBO J,
16,
6646-6658.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Lew,
S.S.Taylor,
and
J.A.Adams
(1997).
Identification of a partially rate-determining step in the catalytic mechanism of cAMP-dependent protein kinase: a transient kinetic study using stopped-flow fluorescence spectroscopy.
|
| |
Biochemistry,
36,
6717-6724.
|
 |
|
|
|
|
 |
J.Zhou,
and
J.A.Adams
(1997).
Is there a catalytic base in the active site of cAMP-dependent protein kinase?
|
| |
Biochemistry,
36,
2977-2984.
|
 |
|
|
|
|
 |
S.R.Hubbard
(1997).
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.
|
| |
EMBO J,
16,
5572-5581.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.D.Grant,
I.Tsigelny,
J.A.Adams,
and
S.S.Taylor
(1996).
Examination of an active-site electrostatic node in the cAMP-dependent protein kinase catalytic subunit.
|
| |
Protein Sci,
5,
1316-1324.
|
 |
|
|
|
|
 |
B.D.Grant,
and
J.A.Adams
(1996).
Pre-steady-state kinetic analysis of cAMP-dependent protein kinase using rapid quench flow techniques.
|
| |
Biochemistry,
35,
2022-2029.
|
 |
|
|
|
|
 |
J.A.Adams
(1996).
Insight into tyrosine phosphorylation in v-Fps using proton inventory techniques.
|
| |
Biochemistry,
35,
10949-10956.
|
 |
|
|
|
|
 |
J.M.Sowadski,
C.A.Ellis,
and
Madhusudan
(1996).
Detergent binding to unmyristylated protein kinase A--structural implications for the role of myristate.
|
| |
J Bioenerg Biomembr,
28,
7.
|
 |
|
|
|
|
 |
M.P.Wymann,
G.Bulgarelli-Leva,
M.J.Zvelebil,
L.Pirola,
B.Vanhaesebroeck,
M.D.Waterfield,
and
G.Panayotou
(1996).
Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.
|
| |
Mol Cell Biol,
16,
1722-1733.
|
 |
|
|
|
|
 |
M.Vihinen,
D.Vetrie,
H.S.Maniar,
H.D.Ochs,
Q.Zhu,
I.Vorechovský,
A.D.Webster,
L.D.Notarangelo,
L.Nilsson,
and
J.M.Sowadski
(1994).
Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.
|
| |
Proc Natl Acad Sci U S A,
91,
12803-12807.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |